Table 3 Clinical data characteristics of multifactor analysis and estimation of the metastasis risk of the development dataset.
Clinical data | nonmetastatic ALNs (n = 259) | metastatic ALNs (n = 272) | p-Value | OR[95%CI] | Score |
|---|---|---|---|---|---|
Physical exam | |||||
Negative | 238 (91.9) | 189 (69.5) | Reference | Reference | 0 |
Positive | 21 (8.1) | 83 (30.5) | 0.0034 | 2.68(1.39–5.16) | 0.984 |
Her-2/neu | |||||
Negative | 211 (81.5) | 176 (64.7) | Reference | Reference | 0 |
Positive | 48 (18.5) | 96 (35.3) | 0.0176 | 1.94(1.12–3.35) | 0.6622 |
Ultrasound grades of ALNs | |||||
Negative | 231 (89.2) | 64 (23.5) | Reference | Reference | 0 |
Positive | 28 (10.8) | 208 (76.5) | < 0.0001 | 23.82(14.11–40.2) | 3.1703 |
LVI | |||||
Negative | 191 (73.7) | 109 (40.1) | Reference | Reference | 0 |
Positive | 68 (26.3) | 163 (59.9) | < 0.0001 | 4.61(2.79–7.61) | 1.5287 |
